Home1734 • TPE
add
Sinphar Pharmaceutical Co Ltd
Previous close
$30.70
Day range
$30.70 - $31.10
Year range
$25.95 - $32.60
Market cap
5.90B TWD
Avg Volume
266.72K
P/E ratio
17.09
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 880.02M | 3.00% |
Operating expense | 286.42M | 9.82% |
Net income | 101.95M | 24.69% |
Net profit margin | 11.59 | 21.11% |
Earnings per share | — | — |
EBITDA | 170.24M | 11.98% |
Effective tax rate | 6.56% | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 994.63M | -15.57% |
Total assets | 6.15B | -2.31% |
Total liabilities | 2.44B | -11.42% |
Total equity | 3.72B | — |
Shares outstanding | 191.39M | — |
Price to book | 1.71 | — |
Return on assets | 3.91% | — |
Return on capital | 4.57% | — |
Cash Flow
Net change in cash
| (TWD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 101.95M | 24.69% |
Cash from operations | 200.63M | 6.62% |
Cash from investing | -89.36M | 0.85% |
Cash from financing | -163.31M | -102.79% |
Net change in cash | -31.02M | -325.79% |
Free cash flow | 27.29M | 140.28% |
About
Founded
1977
Headquarters
Website
Employees
984
